EBS vs NVDA · rev $1.04B vs P/E 58, rev $96.22B
Emergent Biosolutions Inc (EBS) versus NVIDIA Corporation (NVDA) — a side-by-side from cached financials, not a winner call.
Emergent Biosolutions Inc (EBS) is a drug manufacturers - specialty & generic company listed on US.
NVIDIA Corporation (NVDA) is a semiconductors company listed on US. It is led by Jensen Huang.
Latest reported EBS revenue for 2024-12-31 was $1.04B. Net income was -$190.6M. Revenue was down 0.5% from 2023-12-31 to 2024-12-31. EBS currently screens at market cap $416.4M.
Latest reported NVDA revenue for 2026-07-26 was $96.22B. Net income was $59.69B. Revenue was up 17.9% from 2026-04-26 to 2026-07-26. NVDA currently screens at market cap $4.40T and trailing P/E 58.2.
EBS currently screens at market cap $416.4M. NVDA currently screens at market cap $4.40T and trailing P/E 58.2.
Not investment advice. Open the EBS and NVDA stock pages for the full models.
Not investment advice.